Patent Assignment
Reel/Frame 022077/0220
Corrective Assignment to Correct the Execution Date of Inventor Jonathan W. Wiffen from 11 February 2007 to 11 January 2007 Previously Recorded on Reel 022039 Frame 0618. Assignor(S) Hereby Confirms the Assignment of the Invention from Inventors David J. Moody and Jonathan W. Wiffen to Avecia Pharmaceuticals Limited.
Recorded: 2009-01-08
Pages: 6
Assignee
AVECIA PHARMACEUTICALS LIMITED
HEXAGON TOWER, BLACKLEY, P. O. BOX 42, MANCHESTER, M9 8ZS, UNITED KINGDOM
Covered Property
(1)
Process and Intermediate Compounds Useful in the Preparation of Statins, Particularly Rosuvastatin
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 30, 2008
From: MOODY, DAVID J.; WIFFEN, JONATHAN W.
To: AVECIA PHARMACEUTICALS LIMITED
Reel/Frame 022039/0500 →
Change of Name
Dec 30, 2008
From: AVECIA PHARMACEUTICALS LIMITED
To: NPIL PHARMACEUTICALS (UK) LIMITED
Reel/Frame 022039/0618 →
Change of Name
Mar 3, 2010
From: NPIL PHARMACEUTICALS (UK) LIMITED
To: PIRAMAL HEALTHCARE UK LIMITED
Reel/Frame 024021/0384 →
Assignment of Assignor's Interest
Mar 3, 2010
From: PIRAMAL HEALTHCARE UK LIMITED
To: BRADFORD PHARMA LIMITED
Reel/Frame 024021/0412 →
Assignment of Assignor's Interest
Nov 14, 2011
From: BRADFORD PHARMA LIMITED
To: REDX PHARMA LIMITED
Reel/Frame 027221/0001 →
Change of Name
Apr 17, 2015
From: REDX PHARMA LIMITED
To: REDX PHARMA PLC
Reel/Frame 035455/0507 →